Clarivate (NYSE:CLVT) vs. 3 E Network Technology Group (NASDAQ:MASK) Financial Contrast

3 E Network Technology Group (NASDAQ:MASK) and Clarivate (NYSE:CLVT) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, analyst recommendations, earnings, valuation, dividends and institutional ownership.

Institutional & Insider Ownership

85.7% of Clarivate shares are held by institutional investors. 23.2% of Clarivate shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares 3 E Network Technology Group and Clarivate”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
3 E Network Technology Group	$4.84 million	0.26	$760,000.00	N/A	N/A
Clarivate	$2.46 billion	0.61	-$201.10 million	($0.30)	-7.82

3 E Network Technology Group has higher earnings, but lower revenue than Clarivate.

Profitability

This table compares 3 E Network Technology Group and Clarivate’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
3 E Network Technology Group	N/A	N/A	N/A
Clarivate	-8.19%	8.30%	3.63%

Volatility and Risk

3 E Network Technology Group has a beta of -2.85, suggesting that its share price is 385% less volatile than the S&P 500. Comparatively, Clarivate has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and target prices for 3 E Network Technology Group and Clarivate, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
3 E Network Technology Group	1	0	0	0	1.00
Clarivate	3	5	0	0	1.63

Clarivate has a consensus target price of $3.22, suggesting a potential upside of 37.17%. Given Clarivate’s stronger consensus rating and higher possible upside, analysts plainly believe Clarivate is more favorable than 3 E Network Technology Group.

Summary

Clarivate beats 3 E Network Technology Group on 9 of the 11 factors compared between the two stocks.

About 3 E Network Technology Group

3 E Network Technology Group Ltd. operates as a holding company, which engages in the provision of business-to-business information technology business solutions. It offers business solutions to a variety of industries and sectors, including food establishments, real estate, exhibition and conferencing, and clean energy utilities. The company was founded on October 6, 2021 and is headquartered in Guangzhou, China.

About Clarivate

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.